Tamer Rezk

The Royal Free Hospital ·

Area of research

Molecular Biology · Nephrology

Research interest

Research interests include Amyloidosis: Diagnosis, Treatment, Outcomes, Parathyroid Disorders and Treatments, Alzheimer's disease research and treatments, and Cardiovascular Function and Risk Factors.

h-index

citations

5,751

works

NIH funding

—

primary concept

—

✉ Find email ↗

Recent publications

Abstract 15710: Myocardial Ischaemia in Cardiac Amyloidosis, Changing Perspectives

Circulation 2020cited by 3position: middledoi

Native T1 and Extracellular Volume in Transthyretin Amyloidosis

JACC. Cardiovascular imaging 2018cited by 283position: middledoi

Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis

Circulation 2016cited by 1,977position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Julian D. Gillmore · Alnylam Pharmaceuticals (United States)2 papers (2018–2020)Tushar Kotecha · University College London2 papers (2018–2020)Ana Martinez–Naharro · Roland Hill (United Kingdom)2 papers (2018–2020)James Moon · National Medical Center2 papers (2018–2020)Daniel Knight · University College London2 papers (2018–2020)Philip N. Hawkins · The Royal Free Hospital2 papers (2018–2020)Janet A. Gilbertson · The Royal Free Hospital1 papers (2020–2020)Marianna Fontana · Johnson & Johnson (United States)1 papers (2018–2018)Kristopher Knott · St Bartholomew's Hospital1 papers (2020–2020)— · 1 papers (2018–2018)Hui Xue · Soochow University1 papers (2020–2020)Carol Whelan · The Royal Free Hospital1 papers (2018–2018)Peter Kellman · National Heart Lung and Blood Institute1 papers (2020–2020)Candida Cristina Quarta · Alexion Pharmaceuticals (United States)1 papers (2018–2018)Ornella Leone · Santobono Children's Hospital1 papers (2020–2020)Niket Patel · Harvard University1 papers (2020–2020)Marianna Fontana · Twitter (United States)1 papers (2020–2020)— · 1 papers (2018–2018)Arantxa González · Instituto de Salud Carlos III1 papers (2020–2020)Frederick L. Ruberg · Boston University1 papers (2018–2018)